Morbidity and mortality patterns of hospitalised adult HIV/AIDS patients in the era of highly active antiretroviral therapy: A 4-year retrospective review from Zaria, Northern Nigeria

AIDS Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Ogoina, Dimie ^a,b   Obiako, Reginald O ^b   Muktar, Haruna M ^b   Adeiza, Mukhtar ^b   Babadoko, Aliyu ^b   Hassan, Abdulaziz ^b   Bansi, Isa ^b   Iheonye, Henry ^b   Iyanda, Matthew ^b   Tabi Ajayi, Eric ^b  

^a NIGER DELTA UNIVERSITY   (Nigeria)

^b AHMADU BELLO UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873823878     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2012/940580     Document Type: Article

References (40)

1. National Agency for Control of AIDS (NACA), National HIV/AIDS Response Fact Sheet 2011, Update on HIV/AIDS Epidemic and Response in Nigeria. August 2012, http://www.naca.gov.ng/
2. Sani M. U., Mohammed A. Z., Adamu B., Yusuf S. M., Samaila A. A., Borodo M. M., AIDS mortality in a tertiary health institution: a four-year review. Journal of the National Medical Association 2006 98 6 862 866 2-s2.0-33744906294 (Pubitemid 43846243)
3. Ojini F. I., Coker A., Socio-demographic and clinical features of HIV-positive outpatients at a clinic in south-west Nigeria. African Journal of AIDS Research 2007 6 2 139 145 2-s2.0-34648823407 (Pubitemid 47455107)
4. Gyuse A. N., Bassey I. E., Udonwa N. E., Okokon I. B., Philip-Ephraim E. E., HIV/AIDS related mortality among adult medical patients in a tertiary health institution in South-South, Nigeria. Asian Pacific Journal of Tropical Medicine 2010 3 2 141 144 2-s2.0-77950681234 10.1016/S1995-7645(10)60054-5
5. Akolo C., Ukoli C. O., Ladep G. N., Idoko J. A., The clinical features of HIV/AIDS at presentation at the Jos University Teaching Hospital. Nigerian Journal of Medicine 2008 17 1 83 87 2-s2.0-42949137549
6. DeSilva M. B., Merry S. P., Fischer P. R., Rohrer J. E., Isichei C. O., Cha S. S., Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria. AIDS Care 2009 21 1 70 77 2-s2.0-57649123259 10.1080/09540120802017636
7. Agaba P. A., Digin E., Makai R., Apena L., Agbaji O. O., Idoko J. A., Murphy R., Kanki P., Clinical characteristics and predictors of mortality in hospitalized HIV-infected Nigerians. Journal of Infection in Developing Countries 2011 5 5 377 382 2-s2.0-79958115014
8. Eluwa G. I., Badru T., Akpoigbe KJAdverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria. BMC Clinical Pharmacology 2012 12, article 7
9. Obiako O. R., Muktar H. M., Garko S. B., Adverse reactions associated with antiretroviral regimens in adult patients of a University Teaching Hospital HIV Program in Zaria, Northern Nigeria: an observational cohort study. Journal of Antivirals & Antiretrovirals 2012 4 6 13 10.4172/jaa.1000039
10. WHO, Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach. REVISION, 2006, http://www.who.int/en/
11. Haddow L. J., Easterbrook P. J., Mosam A., Khanyile N. G., Parboosing R., Moodley P., Moosa M. Y. S., Defining immune reconstitution inflammatory syndrome: evaluation of expert opinion versus 2 case definitions in a south african cohort. Clinical Infectious Diseases 2009 49 9 1424 1432 2-s2.0-72849126471 10.1086/630208
12. Meintjes G., Lawn S. D., Scano F., Maartens G., French M. A., Worodria W., Elliott J. H., Murdoch D., Wilkinson R. J., Seyler C., John L., van der Loeff M. S., Reiss P., Lynen L., Janoff E. N., Gilks C., Colebunders R., Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. The Lancet Infectious Diseases 2008 8 8 516 523 2-s2.0-47549086736 10.1016/S1473-3099(08)70184-1 (Pubitemid 352005824)
13. Haddow L. J., Colebunders R., Meintjes G., Lawn S. D., Elliott J. H., Manabe Y. C., Bohjanen P. R., Sungkanuparph S., Easterbrook P. J., French M. A., Boulware D. R., Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. The Lancet Infectious Diseases 2010 10 11 791 802 2-s2.0-78049441467 10.1016/S1473-3099(10) 70170-5
14. Bone R. C., Balk R. A., Cerra F. B., Dellinger R. P., Fein A. M., Knaus W. A., Schein R. M., Sibbald W. J., Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992 101 6 1644 1655 2-s2.0-77649201783
15. Federal Ministry of Health, Nigeria, National guideline for HIV and AIDS treatment and care in adolescents and adults. May 2007, http://www.naca.gov.ng/
16. Brinkhof M. W. G., Boulle A., Weigel R., Messou E., Mathers C., Orrell C., Dabis F., Pascoe M., Egger M., Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Medicine 2009 6 4 2-s2.0-66149122978 10.1371/journal.pmed. 1000066 e1000066
17. Krentz H. B., Kliewer G., Gill M. J., Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Medicine 2005 6 2 99 106 2-s2.0-15844379887 10.1111/j.1468-1293.2005.00271.x (Pubitemid 40425973)
18. Mocroft A., Vella S., Benfield T. L., Chiesi A., Miller V., Gargalianos P., D'Arminio Monforte A., Yust I., Bruun J. N., Phillips A. N., Lundgren J. D., Changing patterns of mortality across Europe in patients infected with HIV-1. The Lancet 1998 352 9142 1725 1730 2-s2.0-0032576426 (Pubitemid 28534954)
19. Garko S. B., Ekweani C. N., Anyiam C. A., Duration of hospital stay and mortality in the medical wards of Ahmadu Bello University Teaching Hospital, Kaduna. Annals of African Medicine 2003 2 2 68 71
20. Kolo P., Chijioke A., Gender disparities in mortality among medical admissions of a tertiary health facility in Ilorin, Nigeria. The Internet Journal of Tropical Medicine 2009 6, article 1
21. Ole-Nguyaine S., Crump J. A., Kibiki G. S., Kiang K., Taylor J., Schimana W., Bartlett J. A., Shao J. F., Hamilton J. D., Thielman N. M., HIV-associated morbidity, mortality and diagnostic testing opportunities among inpatients at a referral hospital in northern Tanzania. Annals of Tropical Medicine & Parasitology 2004 98 2 171 179 2-s2.0-12144286266 10.1179/000349804225003163 (Pubitemid 38388885)
22. WHO: Gender and HIV/AIDS,. November 2003, http://www.who.int/
23. Onyemelukwe G. C., Musa B. O., CD4+ and CD8+ lymphocytes and clinical features of HIV seropositive Nigerians on presentation. African Journal of Medicine and Medical Sciences 2002 31 3 229 233 2-s2.0-0038660869
24. Ekong E. E., Akinlade O., Uwah A., Grant-Isibor I., Igbu T., Trend and spectrum of mortality among HIV patients, in the era of HAART-the Nigerian experience. 14, abstract no MoPeC3328 Proceedings of the International Conference on AIDS Jul 2002 7 12
25. Sobhani R., Basavaraj A., Gupta A., Bhave A. S., Kadam D. B., Sangle S. A., Prasad H. B., Choi J., Jospehs J., Gebo K. A., Morde S. N., Bollinger R. C., Kakrani A. L., Mortality & clinical characteristics of hospitalized adult patients with HIV in Pune, India. Indian Journal of Medical Research 2007 126 2 116 121 2-s2.0-35648937566 (Pubitemid 350028043)
26. Etard J. F., Ndiaye I., Thierry-Mieg M., Guèye N. F. N., Guèye P. M., Lanièce I., Dieng A. B., Diouf A., Laurent C., Mboup S., Sow P. S., Delaporte E., Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 2006 20 8 1181 1189 2-s2.0-33646885055 10.1097/01.aids.0000226959.87471.01 (Pubitemid 43786107)
27. Cheung M. C., Pantanowitz L., Dezube B. J., AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Oncologist 2005 10 6 412 426 2-s2.0-22244466800 10.1634/theoncologist.10-6-412 (Pubitemid 40993569)
28. Mamidi A., DeSimone J. A., Pomerantz R. J., Central nervous system infections in individuals with HIV-1 infection. Journal of NeuroVirology 2002 8 3 158 167 2-s2.0-0036301058 10.1080/13550280290049723 (Pubitemid 34732698)
29. Eltom M. A., Mbulaiteye S. M., Dada A. J., Denise-Whitby D., Biggar R. J., Transmission of human herpesvirus 8 by sexual activity among adults in Lagos, Nigeria. AIDS 2002 16 18 2473 2478 2-s2.0-0037032951 10.1097/00002030- 200212060-00014 (Pubitemid 35471695)
30. Uneke C. J., Duhlinska D. D., Njoku M. O., Ngwu B. A. F., Seroprevalence of acquired toxoplasmosis in HIV-infected and apparently healthy individuals in Jos, Nigeria. Parassitologia 2005 47 2 233 236 2-s2.0-31944450380 (Pubitemid 43188248)
31. Ogoina D., Onyemelukwe G., Musa B. O., Babadoko A., Seroprevalence and determinants of human herpes virus 8 infection in adult Nigerians with and without HIV-1 infection. African Health Sciences 2011 11 2 158 162 2-s2.0-79960991207
32. Berry S. A., Manabe Y. C., Moore R. D., Gebo K. A., Hospitalization risk following initiation of highly active antiretroviral therapy. HIV Medicine 2010 11 5 289 298 2-s2.0-77953152370 10.1111/j.1468-1293.2009.00776.x
33. Eze E. U., Kubeyinj E. P., Ofili A. N., Mortality among HIV/AIDS in-patients on admission in a tertiary hospital in Nigeria. Annals of Biomedical Sciences 2009 8 2
34. Saleri N., Capone S., Pietra V., De Iaco G., Del Punta V., Rizzi M., Levi M., Rouamba S., Somé E., Simporé J., Patroni A., Carosi G., Castelli F., Outcome and predictive factors of mortality in hospitalized HIV-patients in burkina faso. Infection 2009 37 2 142 147 2-s2.0-65149097250 10.1007/s15010-008-7406-7
35. Johannessen A., Naman E., Ngowi B. J., Sandvik L., Matee M. I., Aglen H. E., Gundersen S. G., Bruun J. N., Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infectious Diseases 2008 8, article 52 2-s2.0-42949113959 10.1186/1471-2334-8-52 (Pubitemid 351619259)
36. Braitstein P., Brinkhof M. W., Dabis F., Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. The Lancet 2006 367 9513 817 824 2-s2.0-33644835815 10.1016/S0140-6736(06)68337-2 (Pubitemid 43363368)
37. Russell E. C., Charalambous S., Pemba L., Churchyard G. J., Grant A. D., Fielding K., Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study. BMC Public Health 2010 10, article 433 2-s2.0-77954778198 10.1186/1471-2458-10- 433
38. Sullivan P., Associations of anemia, treatments for anemia, and survival in patients with human immunodeficiency virus infection. The Journal of Infectious Diseases 2002 185 supplement 2 S138 S142 2-s2.0-0036255789 10.1086/340203 (Pubitemid 34499450)
39. Kreuzer K. A., Rockstroh J. K., Pathogenesis and pathophysiology of anemia in HIV infection. Annals of Hematology 1997 75 5-6 179 187 2-s2.0-0030780871 10.1007/s002770050340 (Pubitemid 27525045)
40. Ferrand R. A., Herman J., Elgalib A., Cartledge J., Miller R. F., Septic shock and multi-organ failure in HIV infection-'sepsis tuberculosa gravissima'. International Journal of STD and AIDS 2006 17 8 562 564 2-s2.0-33747814116 10.1258/095646206778145578 (Pubitemid 44285734)